Concepedia

Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial

Jonas Bergh, Tom Wiklund, Björn Erikstein, Elisabet Lidbrink, Henrik Lindman, Per Malmström, Pirkko Kellokumpu‐Lehtinen, Nils‐Olof Bengtsson, Gustaf Söderlund, Gun Anker,

The Lancet · 2000 · 342 citations · 20 references

References

20

The Design and Analysis of Sequential Clinical Trials.

David Harrington, John Whitehead · Journal of the American Statistical Association · 1985 · 638 citations

Public Health, Pharmacology, Experimental Design +9

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.

Mark N. Levine, V. Bramwell, Kathleen I. Pritchard et al. · Journal of Clinical Oncology · 1998 · 623 citations

Medicine, Oncology, Pharmacotherapy +10

High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.

W. P. Peters, Maureen Ross, James J. Vredenburgh et al. · Journal of Clinical Oncology · 1993 · 502 citations

Medicine, Oncology, Breast Oncology +10

Conventional Compared with Individualized Chemotherapy for Childhood Acute Lymphoblastic Leukemia

William E. Evans, Mary V. Relling, John H. Rodman et al. · New England Journal of Medicine · 1998 · 500 citations

Medicine, Oncology, Pharmacology +17

Conventional-Dose Chemotherapy Compared with High-Dose Chemotherapy plus Autologous Hematopoietic Stem-Cell Transplantation for Metastatic Breast Cancer

Edward A. Stadtmauer, Anne O'Neill, Lori J. Goldstein et al. · New England Journal of Medicine · 2000 · 464 citations · Full text

Medicine, Oncology, Pharmacology +13